A Double Dose of Good News for Andrx

Check Point Software says revenue is on track; Goldman lowers estimate on Circuit City Stores; plus more of today's stocks in the news

Andrx Corp. (ADRX ) says in a study, an approximate 6% additional lowering of LDL cholesterol was achieved with each doubled dosage of the company's Altocor drug. Merrill reiterates near, and long term buy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.